BioPharma Credit PLC (OTCMKTS:BOPCF – Get Free Report) fell 6.5% on Friday . The company traded as low as $0.9262 and last traded at $0.9262. Approximately 99,452 shares changed hands during mid-day trading, a decline of 71% from the average daily volume of 337,758 shares. The stock had previously closed at $0.9903.
BioPharma Credit Stock Down 6.5%
The company has a fifty day simple moving average of $0.97 and a two-hundred day simple moving average of $0.94.
BioPharma Credit Company Profile
BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.
Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.
Recommended Stories
- Five stocks we like better than BioPharma Credit
- From SaaS-pocalypse to Perfect Storm: Workday’s AI Growth Story Strengthens
- These 3 GARP Stocks Show Why Growth and Value Do Not Have to Clash
- Venture Into High-Volatility Corners of the Market With These 3 ETFs
- 3 Retail Stocks to Watch After a Big Consumer Earnings Week
Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.
